| Pharmaceutical Information |
| Drug Name |
Patiromer |
| Drug ID |
BADD_D01686 |
| Description |
Patiromer is a powder for suspension in water for oral administration, approved in the U.S. as Veltassa in October, 2015. Patiromer is supplied as patiromer sorbitex calcium which consists of the active moiety, patiromer, a non-absorbed potassium-binding polymer, and a calcium-sorbitol counterion. Each gram of patiromer is equivalent to a nominal amount of 2 grams of patiromer sorbitex calcium. The chemical name for patiromer sorbitex calcium is cross-linked polymer of calcium 2-fluoroprop-2-enoate with diethenylbenzene and octa-1,7-diene, combination with D-glucitol. Patiromer sorbitex calcium is an amorphous, free-flowing powder that is composed of individual spherical beads. |
| Indications and Usage |
For the treatment of hyperkalemia. |
| Marketing Status |
approved; investigational |
| ATC Code |
Not Available |
| DrugBank ID |
DB09263
|
| KEGG ID |
D10148
|
| MeSH ID |
C568789
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D0Z2YQ
|
| NDC Product Code |
53436-168; 53436-084; 53436-252 |
| UNII |
1FQ2RY5YHH
|
| Synonyms |
patiromer | Veltassa | RLY 5016 | RLY5016 | RLY-5016 |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
1260643-52-4 |
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
